TNF and inflammatory bowel disease: Immunomodulators (thiopurines or methotrexate) and biologic agents, such as TNF-α inhibitors, are commonly used in the treatment of IBD, but are suspected to promote carcinogenesis by direct genomic alteration or inhibition of physiologic immunosurveillance [19].